Subscriber Content Read Preview
Sanofi-Aventis finished its due diligence of Genzyme's books and facilities but the two drug makers have yet to settle on a price.
Subscriber Content Read Preview
The FDA approved the first three-dimensional mammography system developed by Hologic to screen for breast cancer.
Hundreds of people may have been told they tested positive for syphilis when they didn't actually have the disease, health officials say.
Subscriber Content Read Preview
Cephalon received a subpoena from the U.S. Postal Service's investigative arm seeking information about its cancer-pain drug Fentora.
Subscriber Content Read Preview
Crucell can resume selling its top vaccine Quinvaxem to U.N. agencies, after the World Health Organization said the Dutch biotech company resolved manufacturing problems at its plant in South Korea.
In good news for nursing mothers, the IRS just announced today that breast pumps and other supplies that assist lactation may be deductible medical expenses or can be reimbursed under flexible-spending accounts or health-savings accounts.
Doctors hope that new research recommending less invasive surgery for a certain type of breast cancer could also help them reduce the growing number of women opting for mastectomies.
Subscriber Content Read Preview
Republican officials urged the Supreme Court to intervene quickly and House Democrats called on Justice Clarence Thomas to sit the case out because of his wife's work for groups opposed to the law.
Prenatal surgery for spina bifida, one of the most common disabling birth defects, had significantly more benefit than surgery conducted after birth, and allowed some children to walk who otherwise likely couldn't, according to a major study.
Subscriber Content Read Preview
Sanofi-Aventis reported a 64% drop in fourth-quarter net profit due largely to restructuring costs, and said talks with takeover target Genzyme are continuing, furthering months of suspense surrounding the deal.
House Republicans will use a stopgap spending bill coming to the floor next week as a vehicle to block money for the new health-care law, a top lawmaker said Tuesday.
Teenage girls are about three times as likely as boys to attempt suicide for drug-related reasons, according to an analysis of emergency-room visits.
New research says many breast cancer patients can skip aggressive lymph node surgery without increasing chances for recurrence or death, if their disease shows limited spread.
What's Your Workout: Alison Shaw is trading in her job at Hang Seng Bank to focus on achieving three fitness goals, one of which is to run a 126.6-kilometer ultramarathon.
Federal officials questioned companies that make six cancer drugs about their failure to complete follow-up studies they promised to conduct in exchange for accelerated approval.
Subscriber Content Read Preview
Roche said its cancer drug Avastin helped women suffering from ovarian cancer live longer without their disease worsening, raising the odds the medicine will win approval.
The Obama administration is looking at modifying a workers' long-term-care insurance program included in last year's health-care overhaul, responding to criticism that the program is fiscally unsustainable.
Research report looks at the latest medical findings, including trying to predict scoliosis by tracking a child's shoe size.
Currently, medications for alcoholism work in less than 50% of cases. But genetic research is showing promise in identifying drugs that can help treat alcoholics based on their DNA.
Aches & Claims looks at tattoo-removal products for at-home use.
Subscriber Content Read Preview
The procedure for cardiac-catheterization is getting a makeover in the U.S., with a new approach that proponents say is safer and more comfortable for patients and potentially cheaper.
Subscriber Content Read Preview
Kindred Healthcare agreed to acquire RehabCare Group for about $900 million in stock and cash.
Researchers are exploring whether patients who are hyperventilating should slow down their breathing to boost the carbon dioxide in their systems.
Infants on formula who are fed solid foods before they are 4 months old have a higher risk of becoming obese by age 3 than those starting later, Harvard researchers said.
Subscriber Content Read Preview
Sanofi is taking longer than expected on due diligence for its proposed acquisition of Genzyme, but the companies are confident they can seal a deal this week.
Subscriber Content Read Preview
Aetna's fourth-quarter earnings rose 30% as the health insurer's medical-claims costs declined, though revenue from premiums fell.
Subscriber Content Read Preview
The doctor who runs Opko Health sharply escalated his purchases of the health-care company's shares last month, and another insider bought shares too.
Subscriber Content Read Preview
BG Medicine rose 15%, Endocyte gained 29%, and MedQuist Holdings ended up 13%. A fourth, Trunkbow International, declined.
States challenging the massive health-care law enacted last year are employing different tactics in their push for swift Supreme Court review of their legal cases.
The Justice Department plans to ask a federal judge to make public the proposed statements the government wants tobacco companies to publish about the dangers of their products.
Subscriber Content Read Preview
The new leaders of the world's two biggest drug companies made divergent choices this week in balancing the billions of dollars they spend on drug research against pressure to deliver better returns for investors.
The Senate voted against repealing the health-care overhaul but approved a measure eliminating a tax requirement that had irked small businesses.
House Republicans are debating whether to propose new limits on the growth of Medicare and other entitlement programs, weighing a gamble that voters are more concerned about trimming the deficit than holding on to promised benefits.
Subscriber Content Read Preview
The Susan G. Komen for the Cure organization, a breast-cancer patient-advocacy group, said it isn't promoting the use of the drug Avastin for women who haven't previously taken it.
Subscriber Content Read Preview
Merck swung to a loss on a write-down of the value of an experimental heart drug recently linked to safety concerns, and the drug maker abandoned its prior long-term profit forecast.
Researchers looked at the health histories of all 409 Hollywood stars nominated for best actor and best actress in the 82-year history of the Oscars.
The Cleveland Clinic banned hiring smokers since 2007, and hospitals in at least eight states have recently done the same, the NYT says.
Also: One syphilis test has high false-positive rate; MannKind cuts workforce; ideal pain relief for labor?
Only 27% of primary-care docs who treat adults surveyed said they had all adult vaccines on hand.
Billy Demong, the first U.S. athlete to win a gold medal in Nordic Combined Skiing in 86 years, on his grueling workout schedule ahead of competing in the world championships.
Journal articles on nation-wide flu vaccination in 1976:
Just how much beef is in fast-food meat? It can be tough for consumers to know, since the data on the content of some of their favorite food items are limited and confusing.
As long-term-care insurance gets costlier and harder to find, insurers are rolling out other options. We weigh the pros and cons.
With exercise intruding ever-more frequently on intimacy, counselors are proposing a new vow: For fitter or fatter.
The FDA hasn't approved Truvada to prevent HIV infection, but because it's on the market it's expected people will use it as such.
How can you comfort someone grieving the death of a loved one? What can you say that might adequately offer solace? "I'm sorry" doesn't seem to cut it.
Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.
The latest news and analysis delivered to your in-box. Check the boxes below to sign up.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)